Literature DB >> 3010363

A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.

R G Lister, S E File.   

Abstract

The activity of rats in a holeboard test is reduced 30, 90, and 240 min after treatment with a single dose of lorazepam. The administration of a benzodiazepine antagonist (RO 15-1788) 20 min before the holeboard test (i.e., 10, 70, or 220 min after lorazepam administration) reverses the hypoactivity of animals tested 30 min after treatment with lorazepam, partially reverses the hypoactivity of animals tested 90 min after receiving lorazepam, but is without effect on the hypoactivity observed 240 min after treatment with the benzodiazepine. If, however, RO 15-1788 is given at the same time as lorazepam then it reverses the hypoactivity seen 4 h later. The results of these experiments demonstrate that a benzodiazepine can exert a behavioral effect at a time when it no longer appears to be acting at central benzodiazepine receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010363     DOI: 10.1007/bf00178518

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Profile of acute tolerance to three sedative anxiolytics.

Authors:  E H Ellinwood; M Linnoila; M E Easler; D W Molter
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  The behavioural effects of lorazepam are poorly related to its concentration in the brain.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

3.  Withdrawal from ethanol: simple quantitative behavioral tests for its evaluation.

Authors:  L A Pohorecky
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

4.  Changes in regional concentrations in the rat brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid during the development of tolerance to the sedative action of chlordiazepoxide.

Authors:  R G Lister; S E File
Journal:  J Pharm Pharmacol       Date:  1983-09       Impact factor: 3.765

5.  Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam.

Authors:  S E Lukas; R R Griffiths
Journal:  Science       Date:  1982-09-17       Impact factor: 47.728

6.  Evidence for intrinsic behavioural activity of the benzodiazepine antagonist, Ro15-1788, in male mice.

Authors:  R J Rodgers; A J Waters; S Rosenfield
Journal:  Pharmacol Biochem Behav       Date:  1983-11       Impact factor: 3.533

7.  An antagonist-induced benzodiazepine abstinence syndrome.

Authors:  H C Rosenberg; T H Chiu
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

8.  Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.

Authors:  R G Lister; D R Abernethy; D J Greenblatt; S E File
Journal:  J Chromatogr       Date:  1983-10-14

9.  Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.

Authors:  C D Wise; B D Berger; L Stein
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  1 in total

1.  The role of the benzodiazepine receptor in mediating long-lasting anticonvulsant effects and the late-appearing reductions in motor activity and exploration.

Authors:  S E File; L J Wilks; P S Mabbutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.